戻る Agenda
Ready or Not: Business Continuity Planning
Session Chair(s)
Leigh Shultz, PHD, PMP
Executive Director, Human Health Commercial Operations
Merck & Co., Inc., United States
This panel discussion will discuss business continuity planning as a key operational tool across the healthcare ecosystem, with a focus on biopharmaceutical companies. Representatives with experience across a variety of companies will share their insights and experiences with business continuity planning.
Learning Objective : Assess which business processes are most critical to maintain in the event of a business disruption, key steps in developing business continuity plans, and linkages to risk management and crisis management.
Speaker(s)
Panelist
Jinus Moghbeli Pashai
Amgen, United States
Director of Risk Managament
Panelist
Mobeen Faqih, PHD, MBA
Bristol-Myers Squibb, United States
Lead - Business Continuity (Supply Chain)
Panelist
Colleen Merritt Severyn, PHD
Merck & Co., Inc., United States
Director, Business Development, Supplier and Alliance Management, GRA